Course Description
Doctoral students from biochemistry, bioengineering, pharmacology, pharmacy, and other fields will work as part of interdisciplinary teams to simulate the drug development process starting with a druggable lead and ending with a report to “upper management” giving the scientific and business plan for development into an approved drug product. The course will follow an intensive, all-day, short-course format for ten consecutive weekdays with faculty lectures and student project teamwork. The goal of the course is to teach students the multifaceted process needed to bring a drug from concept to market in the context of open-ended, student-driven, collaborative projects addressing real-world problems in pharmaceutical development.
Course syllabus
May 27 - Introduction to class and pharmaceutical development, Project teamwork and communication
May 28 - From drug lead to drug molecule
May 29 - Target indication, patient population
May 30 - Drug manufacturing scale up and GMP
June 2 - Formulation, route of administration, drug delivery systems
June 3 - Design of IND-enabling studies: CMC, PK/PD and toxicology
June 4 - Clinical trial design
June 5 - Pharmaceutical marketing
June 6 - Oral presentations and reports / business plan
June 9 - Final presentations
Please contact Mark Prausnitz for a registration permit or for more information.